Major Depression Is a Risk Factor for Low Bone Mineral Density: A Meta-Analysis

Biological Psychiatry

Volumn 66, Issue 5, 2009, Pages 423-432

  Yirmiya, Raz ^a   Bab, Itai ^a  

^a HEBREW UNIVERSITY OF JERUSALEM   (Israel)

Author keywords

Bone mineral density; major depression; meta analysis; osteoporosis

Indexed keywords

BIOLOGICAL MARKER; OSTEOCALCIN;

ARTICLE; BIBLIOGRAPHIC DATABASE; BIOSIS; BONE DENSITY; BONE TURNOVER; DIAGNOSTIC AND STATISTICAL MANUAL OF MENTAL DISORDERS; DISEASE ASSOCIATION; FOREARM; HIP; HUMAN; MAJOR DEPRESSION; MEDLINE; OSTEOLYSIS; OSTEOPOROSIS; POSTMENOPAUSE; PREMENOPAUSE; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PSYCINFO; QUANTITATIVE ANALYSIS; QUESTIONNAIRE; RISK FACTOR; SELF CONCEPT; SEX DIFFERENCE; SPINE; SYSTEMATIC REVIEW; URINE LEVEL;

BIOLOGICAL MARKERS; BONE DENSITY; BONE RESORPTION; DEPRESSIVE DISORDER, MAJOR; FEMALE; HUMANS; MALE; POSTMENOPAUSE; PREMENOPAUSE; RISK FACTORS; SEX CHARACTERISTICS;

EID: 68049127806     PISSN: 00063223     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.biopsych.2009.03.016     Document Type: Article

References (85)

1. Melton III L.J. Epidemiology worldwide. Endocrinol Metab Clin North Am 32 (2003) 1-13
2. US Department of Health and Human Services: Office of the Surgeon General. Bone Health and Osteoporosis: A Report of the Surgeon General. 2004. http://www.surgeongeneral.gov/library/bonehealth/ Accessed December 1, 2008
3. Kanis J.A., Oden A., Johnell O., Johansson H., De Laet C., Brown J., et al. The use of clinical risk factors enhances the performance of BMD in the prediction of hip and osteoporotic fractures in men and women. Osteoporos Int 18 (2007) 1033-1046
4. Klibanski A., Adams-Campbell L., Bassford T., Blair S.N., Boden S.D., Dickersin K., et al. Osteoporosis prevention, diagnosis, and therapy. JAMA 285 (2001) 785-795
5. Cizza G., Ravn P., Chrousos G.P., and Gold P.W. Depression: A major, unrecognized risk factor for osteoporosis?. Trends Endocrinol Metab 12 (2001) 198-203
6. Mezuk B., Eaton W.W., and Golden S.H. Depression and osteoporosis: Epidemiology and potential mediating pathways. Osteoporos Int 19 (2008) 1-12
7. Williams L.J., Pasco J.A., Jacka F.N., Henry M.J., Dodd S., and Berk M. Depression and Bone Metabolism. A review. Psychother Psychosom 78 (2008) 16-25
8. Murray C.J., and Lopez A.D. Alternative projections of mortality and disability by cause 1990-2020: Global burden of disease study. Lancet 349 (1997) 1498-1504
9. Blazer D.G., Kessler R.C., McGonagle K.A., and Swartz M.S. The prevalence and distribution of major depression in a national community sample: The national comorbidity survey. Am J Psychiatry 151 (1994) 979-986
10. Yirmiya R., Goshen I., Bajayo A., Kreisel T., Feldman S., Tam J., et al. Depression induces bone loss through stimulation of the sympathetic nervous system. Proc Natl Acad Sci U S A 103 (2006) 16876-16881
11. Gold D.T., and Solimeo S. Osteoporosis and depression: A historical perspective. Curr Osteoporos Rep 4 (2006) 134-139
12. Ilias I., Alesci S., Gold P.W., and Chrousos G.P. Depression and osteoporosis in men: Association or casual link?. Hormones 5 (2006) 9-16
13. Lyles K.W. Osteoporosis and depression: Shedding more light upon a complex relationship. J Am Geriatr Soc 49 (2001) 827-828
14. Altindag O., Altindag A., Asoglu M., Gunes M., Soran N., and Deveci Z. Relation of cortisol levels and bone mineral density among premenopausal women with major depression. Int J Clin Pract 61 (2007) 416-420
15. Amsterdam J.D., and Hooper M.B. Bone density measurement in major depression. Prog Neuro-Psychopharmacology Biol Psychiatry 22 (1998) 267-277
16. Diem S.J., Blackwell T.L., Stone K.L., Yaffe K., Cauley J.A., Whooley M.A., et al. Depressive symptoms and rates of bone loss at the hip in older women. J Am Geriatr Soc 55 (2007) 824-831
17. Eskandari F., Martinez P.E., Torvik S., Phillips T.M., Sternberg E.M., Mistry S., et al. Low bone mass in premenopausal women with depression. Arch Intern Med 167 (2007) 2329-2336
18. Furlan P.M., Ten Have T., Cary M., Zemel B., Wehrli F., Katz I.R., et al. The role of stress-induced cortisol in the relationship between depression and decreased bone mineral density. Biol Psychiatry 57 (2005) 911-917
19. Herran A., Amado J.A., Garcia-Unzueta M.T., Vazquez-Barquero J.L., Perera L., and Gonzalez-Macias J. Increased bone remodeling in first-episode major depressive disorder. Psychosom Med 62 (2000) 779-782
20. Jacka F.N., Pasco J.A., Henry M.J., Kotowicz M.A., Dodd S., Nicholson G.C., et al. Depression and bone mineral density in a community sample of perimenopausal women: Geelong osteoporosis study. Menopause 12 (2005) 88-91
21. Kahl K.G., Greggersen W., Rudolf S., Stoeckelhuber B.M., Bergmann-Koester C.U., Dibbelt L., and Schweiger U. Bone mineral density, bone turnover, and osteoprotegerin in depressed women with and without borderline personality disorder. Psychosom Med 68 (2006) 669-674
22. Kahl K.G., Rudolf S., Stoeckelhuber B.M., Dibbelt L., Gehl H.B., Markhof K., et al. Bone mineral density, markers of bone turnover, and cytokines in young women with borderline personality disorder with and without comorbid major depressive disorder. Am J Psychiatry 162 (2005) 168-174
23. Kavuncu V., Kuloglu M., Kaya A., Sahin S., Atmaca M., and Firidin B. Bone metabolism and bone mineral density in premenopausal women with mild depression. Yonsei Med J 43 (2002) 101-108
24. Michelson D., Stratakis C., Hill L., Reynolds J., Galliven E., Chrousos G., and Gold P. Bone mineral density in women with depression. N Engl J Med 335 (1996) 1176-1181
25. Mussolino M.E., Jonas B.S., and Looker A.C. Depression and bone mineral density in young adults: Results from NHANES III. Psychosom Med 66 (2004) 533-537
26. Ozsoy S., Esel E., Turan M.T., Kula M., Demir H., Kartalci S., and Kokbudak Z. [Is there any alteration in bone mineral density in patients with depression?]. Turk Psikiyatri Derg 16 (2005) 77-82
27. Reginster J.Y., Deroisy R., Paul I., Hansenne M., and Ansseau M. Depressive vulnerability is not an independent risk factor for osteoporosis in postmenopausal women. Maturitas 33 (1999) 133-137
28. Robbins J., Hirsch C., Whitmer R., Cauley J., and Harris T. The association of bone mineral density and depression in an older population. J Am Geriatr Soc 49 (2001) 732-736
29. Schweiger U., Deuschle M., Korner A., Lammers C.H., Schmider J., Gotthardt U., et al. Low lumbar bone mineral density in patients with major depression. Am J Psychiatry 151 (1994) 1691-1693
30. Schweiger U., Weber B., Deuschle M., and Heuser I. Lumbar bone mineral density in patients with major depression: Evidence of increased bone loss at follow-up. Am J Psychiatry 157 (2000) 118-120
31. Sogaard A.J., Joakimsen R.M., Tverdal A., Fonnebo V., Magnus J.H., and Berntsen G.K. Long-term mental distress, bone mineral density and non-vertebral fractures. The Tromso study. Osteoporos Int 16 (2005) 887-897
32. Spangler L., Scholes D., Brunner R.L., Robbins J., Reed S.D., Newton K.M., et al. Depressive symptoms, bone loss, and fractures in postmenopausal women. J Gen Intern Med 23 (2008) 567-574
33. Whooley M.A., Cauley J.A., Zmuda J.M., Haney E.M., and Glynn N.W. Depressive symptoms and bone mineral density in older men. J Geriatr Psychiatry Neurol 17 (2004) 88-92
34. Whooley M.A., Kip K.E., Cauley J.A., Ensrud K.E., Nevitt M.C., and Browner W.S. Depression, falls, and risk of fracture in older women. Study of Osteoporotic Fractures Research Group. Arch Intern Med 159 (1999) 484-490
35. Wong S.Y., Lau E.M., Lynn H., Leung P.C., Woo J., Cummings S.R., and Orwoll E. Depression and bone mineral density: Is there a relationship in elderly Asian men?. Results from Mr. Os (Hong Kong). Osteoporos Int 16 (2005) 610-615
36. Yazici A.E., Bagis S., Tot S., Sahin G., Yazici K., and Erdogan C. Bone mineral density in premenopausal women with major depression. Joint Bone Spine 72 (2005) 540-543
37. Yazici K.M., Akinci A., Sutcu A., and Ozcakar L. Bone mineral density in premenopausal women with major depressive disorder. Psychiatry Res 117 (2003) 271-275
38. Cohen J. Statistical Power Analysis for the Behavioral Sciences (1977), Academic Press, New York
39. Egger M., Davey S.G., Schneider M., and Minder C. Bias in meta-analysis detected by a simple, graphical test. BMJ 315 (1997) 629-634
40. Begg C.B., and Mazumdar M. Operating characteristics of a rank correlation test for publication bias. Biometrics 50 (1994) 1088-1101
41. American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders. 4th Edition (1994), American Psychiatric Press, Washington, DC
42. Rosenthal R. Meta-analysis: A review. Psychosom Med 53 (1991) 247-271
43. Riggs B.L., Khosla S., and Melton III L.J. Sex steroids and the construction and conservation of the adult skeleton. Endocr Rev 23 (2002) 279-302
44. Bale T.L. Stress sensitivity and the development of affective disorders. Horm Behav 50 (2006) 529-533
45. Peeters F., Nicholson N.A., and Berkhof J. Cortisol responses to daily events in major depressive disorder. Psychosom Med 65 (2003) 836-841
46. Yesavage J.A. Geriatric depression scale. Psychopharmacol Bull 24 (1988) 709-711
47. Irwin M., Artin K.H., and Oxman M.N. Screening for depression in the older adult: Criterion validity of the 10-item Center for Epidemiological Studies Depression Scale (CES-D). Arch Intern Med 159 (1999) 1701-1704
48. Vogel J.M., Wasnich R.D., and Ross P.D. The clinical relevance of calcaneus bone mineral measurements: A review. Bone Miner 5 (1988) 35-58
49. Ho A.Y., and Kung A.W. Determinants of peak bone mineral density and bone area in young women. J Bone Miner Metab 23 (2005) 470-475
50. MacInnis R.J., Cassar C., Nowson C.A., Paton L.M., Flicker L., Hopper J.L., et al. Determinants of bone density in 30- to 65-year-old women: A co-twin study. J Bone Miner Res 18 (2003) 1650-1656
51. Cauley J.A., Fullman R.L., Stone K.L., Zmuda J.M., Bauer D.C., Barrett-Connor E., et al. Factors associated with the lumbar spine and proximal femur bone mineral density in older men. Osteoporos Int 16 (2005) 1525-1537
52. Diem S.J., Blackwell T.L., Stone K.L., Yaffe K., Haney E.M., Bliziotes M.M., and Ensrud K.E. Use of antidepressants and rates of hip bone loss in older women: The study of osteoporotic fractures. Arch Intern Med 167 (2007) 1240-1245
53. Haney E.M., Chan B.K., Diem S.J., Ensrud K.E., Cauley J.A., Barrett-Connor E., et al. Association of low bone mineral density with selective serotonin reuptake inhibitor use by older men. Arch Intern Med 167 (2007) 1246-1251
54. Richards J.B., Papaioannou A., Adachi J.D., Joseph L., Whitson H.E., Prior J.C., and Goltzman D. Effect of selective serotonin reuptake inhibitors on the risk of fracture. Arch Intern Med 167 (2007) 188-194
55. Williams L.J., Henry M.J., Berk M., Dodd S., Jacka F.N., Kotowicz M.A., et al. Selective serotonin reuptake inhibitor use and bone mineral density in women with a history of depression. Int Clin Psychopharmacol 23 (2008) 84-87
56. Ensrud K.E., Blackwell T., Mangione C.M., Bowman P.J., Bauer D.C., Schwartz A., et al. Central nervous system active medications and risk for fractures in older women. Arch Intern Med 163 (2003) 949-957
57. Liu B., Anderson G., Mittmann N., To T., Axcell T., and Shear N. Use of selective serotonin-reuptake inhibitors of tricyclic antidepressants and risk of hip fractures in elderly people. Lancet 351 (1998) 1303-1307
58. Ziere G., Dieleman J.P., van der Cammen T.J., Hofman A., Pols H.A., and Stricker B.H. Selective serotonin reuptake inhibiting antidepressants are associated with an increased risk of nonvertebral fractures. J Clin Psychopharmacol 28 (2008) 411-417
59. Warden S.J., Bliziotes M.M., Wiren K.M., Eshleman A.J., and Turner C.H. Neural regulation of bone and the skeletal effects of serotonin (5-hydroxytryptamine). Mol Cell Endocrinol 242 (2005) 1-9
60. Bab I., and Yirmiya R. Depression, selective serotonin re-uptake inhibitors and the regulation of bone mass. IBMS Bonekey 6 (2009) 8-15
61. Battaglino R., Fu J., Spate U., Ersoy U., Joe M., Sedaghat L., and Stashenko P. Serotonin regulates osteoclast differentiation through its transporter. J Bone Miner Res 19 (2004) 1420-1431
62. Collet C., Schiltz C., Geoffroy V., Maroteaux L., Launay J.M., and de Vernejoul M.C. The serotonin 5-HT2B receptor controls bone mass via osteoblast recruitment and proliferation. FASEB J 22 (2008) 418-427
63. Gustafsson B.I., Thommesen L., Stunes A.K., Tommeras K., Westbroek I., Waldum H.L., et al. Serotonin and fluoxetine modulate bone cell function in vitro. J Cell Biochem 98 (2006) 139-151
64. Yadav V.K., Ryu J.H., Suda N., Tanaka K.F., Gingrich J.A., Schutz G., et al. Lrp5 controls bone formation by inhibiting serotonin synthesis in the duodenum. Cell 135 (2008) 825-837
65. Christenson R.H. Biochemical markers of bone metabolism: An overview. Clin Biochem 30 (1997) 573-593
66. Cherruau M., Morvan F.O., Schirar A., and Saffar J.L. Chemical sympathectomy-induced changes in TH-, VIP-, and CGRP-immunoreactive fibers in the rat mandible periosteum: Influence on bone resorption. J Cell Physiol 194 (2003) 341-348
67. Elefteriou F., Ahn J.D., Takeda S., Starbuck M., Yang X., Liu X., et al. Leptin regulation of bone resorption by the sympathetic nervous system and CART. Nature 434 (2005) 514-520
68. Hill E.L., and Elde R. Distribution of CGRP-, VIP-, D beta H-, SP-, and NPY-immunoreactive nerves in the periosteum of the rat. Cell Tissue Res 264 (1991) 469-480
69. Hohmann E.L., Elde R.P., Rysavy J.A., Einzig S., and Gebhard R.L. Innervation of periosteum and bone by sympathetic vasoactive intestinal peptide-containing nerve fibers. Science 232 (1986) 868-871
70. Imai S., and Matsusue Y. Neuronal regulation of bone metabolism and anabolism: Calcitonin gene-related peptide-, substance P-, and tyrosine hydroxylase-containing nerves and the bone. Microsc Res Tech 58 (2002) 61-69
71. Takeda S., Elefteriou F., Levasseur R., Liu X., Zhao L., Parker K.L., et al. Leptin regulates bone formation via the sympathetic nervous system. Cell 111 (2002) 305-317
72. Takeeeda T.S., and Karsenty G. Molecular bases of the sympathetic regulation of bone mass. Bone 42 (2008) 837-840
73. Tam J., Trembovler V., Di Marzo V., Petrosino S., Leo G., Alexandrovich A., et al. The cannabinoid CB1 receptor regulates bone formation by modulating adrenergic signaling. FASEB J 22 (2008) 285-294
74. Togari A. Adrenergic regulation of bone metabolism: Possible involvement of sympathetic innervation of osteoblastic and osteoclastic cells. Microsc Res Tech 58 (2002) 77-84
75. Wong M.L., Kling M.A., Munson P.J., Listwak S., Licinio J., Prolo P., et al. Pronounced and sustained central hypernoradrenergic function in major depression with melancholic features: Relation to hypercortisolism and corticotropin-releasing hormone. Proc Natl Acad Sci U S A 97 (2000) 325-330
76. Alesci S., De Martino M.U., Ilias I., Gold P.W., and Chrousos G.P. Glucocorticoid-induced osteoporosis: from basic mechanisms to clinical aspects. Neuroimmunomodulation 12 (2005) 1-19
77. Berris K.K., Repp A.L., and Kleerekoper M. Glucocorticoid-induced osteoporosis. Curr Opin Endocrinol Diabetes Obes 14 (2007) 446-450
78. Alesci S., Martinez P.E., Kelkar S., Ilias I., Ronsaville D.S., Listwak S.J., et al. Major depression is associated with significant diurnal elevations in plasma interleukin-6 levels, a shift of its circadian rhythm, and loss of physiological complexity in its secretion: Clinical implications. J Clin Endocrinol Metab 90 (2005) 2522-2530
79. Goshen I., Kreisel T., Ben-Menachem-Zidon O., Licht T., Weidenfeld J., Ben-Hur T., and Yirmiya R. Brain interleukin-1 mediates chronic stress-induced depression in mice via adrenocortical activation and hippocampal neurogenesis suppression. Mol Psychiatry 13 (2008) 717-728
80. Goshen I., and Yirmiya R. Interleukin-1 (IL-1): A central regulator of stress responses. Front Neuroendocrinol 30 (2009) 30-45
81. Pollak Y., and Yirmiya R. Cytokine-induced changes in mood and behaviour: Implications for "depression due to a general medical condition", immunotherapy and antidepressive treatment. Int J Neuropsychopharmacol 5 (2002) 389-399
82. Licinio J., and Wong M.L. The role of inflammatory mediators in the biology of major depression: Central nervous system cytokines modulate the biological substrate of depressive symptoms, regulate stress-responsive systems, and contribute to neurotoxicity and neuroprotection. Mol Psychiatry 4 (1999) 317-327
83. Manolagas S.C. Role of cytokines in bone resorption. Bone 17 (1995) 63S-67S
84. Manolagas S.C. The role of IL-6 type cytokines and their receptors in bone. Ann N Y Acad Sci 840 (1998) 194-204
85. Kondo A., and Togari A. In vivo stimulation of sympathetic nervous system modulates osteoblastic activity in mouse Calvaria. Am J Physiol Endocrinol Metab 285 (2003) E661-E667